These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9135823)

  • 1. Calcitonin inhibits phospholipase A2 and collagenase activity of human osteoarthritic chondrocytes.
    Hellio MP; Peschard MJ; Cohen C; Richard M; Vignon E
    Osteoarthritis Cartilage; 1997 Mar; 5(2):121-8. PubMed ID: 9135823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin-stimulated phospholipase A2 and collagenase activation in chondrocytes from human osteoarthritic articular cartilage.
    Richard M; Vignon E; Peschard MJ; Broquet P; Carret JP; Louisot P
    FEBS Lett; 1991 Jan; 278(1):38-40. PubMed ID: 1847113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes.
    Sondergaard BC; Wulf H; Henriksen K; Schaller S; Oestergaard S; Qvist P; Tankó LB; Bagger YZ; Christiansen C; Karsdal MA
    Osteoarthritis Cartilage; 2006 Aug; 14(8):759-68. PubMed ID: 16549372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy.
    Tchetina EV; Di Battista JA; Zukor DJ; Antoniou J; Poole AR
    Arthritis Res Ther; 2007; 9(4):R75. PubMed ID: 17683641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase A2 activity in human osteoarthritic cartilage.
    Vignon E; Mathieu P; Louisot P; Vilamitjana J; Harmand MF; Richard M
    J Rheumatol Suppl; 1989 Aug; 18():35-8. PubMed ID: 2553968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of release of secretory nonpancreatic phospholipase A2 from human articular chondrocytes.
    Pruzanski W; Bogoch E; Katz A; Wloch M; Stefanski E; Grouix B; Sakotic G; Vadas P
    J Rheumatol; 1995 Nov; 22(11):2114-9. PubMed ID: 8596153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiologic state of the cells.
    Tardif G; Pelletier JP; Dupuis M; Geng C; Cloutier JM; Martel-Pelletier J
    Arthritis Rheum; 1999 Jun; 42(6):1147-58. PubMed ID: 10366107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes.
    Kim JH; Huh JE; Baek YH; Lee JD; Choi DY; Park DS
    J Ethnopharmacol; 2011 Mar; 134(2):234-42. PubMed ID: 21182922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
    Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
    J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human urinary trypsin inhibitor inhibits the activation of pro-matrix metalloproteinases and proteoglycans release in rabbit articular cartilage.
    Hashimoto K; Nagao Y; Kato K; Mori Y; Ito A
    Life Sci; 1998; 63(3):205-13. PubMed ID: 9698050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Toll-like receptor-dependent collagenase expression in chondrocytes.
    Zhang Q; Hui W; Litherland GJ; Barter MJ; Davidson R; Darrah C; Donell ST; Clark IM; Cawston TE; Robinson JH; Rowan AD; Young DA
    Ann Rheum Dis; 2008 Nov; 67(11):1633-41. PubMed ID: 18258708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the effect of a glycosaminoglycan-peptide complex on the degradative enzyme activities in human osteoarthritic cartilage.
    Vignon E; Martin A; Mathieu P; Conrozier T; Louisot P; Richard M
    Clin Rheumatol; 1990 Sep; 9(3):383-8. PubMed ID: 2261738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
    Tetlow LC; Adlam DJ; Woolley DE
    Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha.
    Lefebvre V; Peeters-Joris C; Vaes G
    Biochim Biophys Acta; 1991 Aug; 1094(1):8-18. PubMed ID: 1653026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of human and salmon calcitonin on human articular chondrocytes cultivated in clusters.
    Franchimont P; Bassleer C; Henrotin Y; Gysen P; Bassleer R
    J Clin Endocrinol Metab; 1989 Aug; 69(2):259-66. PubMed ID: 2753973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human articular cartilage.
    Freemont AJ; Byers RJ; Taiwo YO; Hoyland JA
    Ann Rheum Dis; 1999 Jun; 58(6):357-65. PubMed ID: 10340960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent hydrostatic pressure inhibits matrix metalloproteinase and pro-inflammatory mediator release from human osteoarthritic chondrocytes in vitro.
    Trindade MC; Shida J; Ikenoue T; Lee MS; Lin EY; Yaszay B; Yerby S; Goodman SB; Schurman DJ; Smith RL
    Osteoarthritis Cartilage; 2004 Sep; 12(9):729-35. PubMed ID: 15325639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles.
    Maeda S; Dean DD; Gay I; Schwartz Z; Boyan BD
    J Bone Miner Res; 2001 Jul; 16(7):1281-90. PubMed ID: 11450704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of calcitonin on IL-1 stimulated chondrocytes by regulating MMPs/TIMP-1 ratio via suppression of p50-NF-κB pathway.
    Bai X; Guo A; Li Y
    Biosci Biotechnol Biochem; 2019 Apr; 83(4):598-604. PubMed ID: 30582416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
    Yasuda T; Poole AR
    Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.